NCT02270671

Brief Summary

Attention bias modification training (ABMT) is a computer-based attention training programme designed to modify the way a person's attention is directed to mild threats in the environment. What a person focuses their attention on plays an important role in how safe or unsafe they feel in certain situations. Much research has shown that people with high levels of anxiety tend to focus their attention on negative information in their surroundings. The purpose of ABMT is to set in place attention patterns that do not lead to excessive anxiety. The present study will test whether this treatment is effective in reducing social anxiety in 15-18 year olds in school settings. The study design consists of two phases. During Phase 1 participants will complete a screening questionnaire in relation to their wellbeing and emotions. This questionnaire will include a measure of the affective, cognitive, and behavioural components of social anxiety in adolescence. Depending on their suitability (i.e. scoring above a cut-off on a standardised measure of social anxiety in Phase 1 of the study), participants may then be invited to take part in a 4-week computer-based attention training programme. The purpose of this phase is to see if ABMT will help young people feel less worried or nervous in social situations by teaching them to focus on their environment differently. Previous research containing attention training tasks similar to this training programme suggests that attention training can reduce symptoms of social anxiety in adolescents. Individuals who are invited to take part in the training session will be randomly assigned to either the intervention (ABMT) or placebo (inactive) group. Both groups will be asked to complete a 4-week programme involving one computer training session per week (each session takes approximately 15-20 minutes). Questionnaires will also be given to participants to complete before and after the intervention, along with a 12-week follow up assessment. These will include questionnaires to measure social anxiety, depressive symptoms, and fears in relation to negative evaluation. Each questionnaire will take approximately 40 minutes to complete. Participants will not know whether they have received the intervention or placebo training until after the intervention.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable anxiety

Timeline
Completed

Started Oct 2014

Shorter than P25 for not_applicable anxiety

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

October 9, 2014

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 21, 2014

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
3.6 years until next milestone

Results Posted

Study results publicly available

November 20, 2018

Completed
Last Updated

November 20, 2018

Status Verified

November 1, 2018

Enrollment Period

7 months

First QC Date

October 9, 2014

Results QC Date

August 17, 2016

Last Update Submit

November 14, 2018

Conditions

Keywords

Social AnxietySocial PhobiaDepressionAttention Bias Modification Training

Outcome Measures

Primary Outcomes (2)

  • Threat Bias Measurement at 4-week Post-intervention and 12-week Follow-up

    The bias measurement protocol consists of 120 trials (80 angry-neutral and 40 neutral-neutral presentations). Angry face location, probe location, probe type and actor are all fully counterbalanced in presentation. The participant must perform with more than 70% accuracy on the first 10 trials.The threat bias measurement consisted of 120 trials of the dot-probe task, 80 of which contained angry-neutral face pairs and 40 of which contained neutral-neutral face pairs. The threat bias score equal the mean of neutral NT trials minus mean of threat NT trials. A threat bias scores \>0 indicate a bias towards threat, whereas scores \<0 mean that the participant is slower to respond to threatening stimuli than neutral stimuli. Reaction times were measured in milliseconds.

    Post-intervention (week 4), and 12-week follow-up

  • Social Phobia and Anxiety at 4-week Post-intervention and 12-week Follow-up

    The Social Phobia and Anxiety Inventory for Children (SPAI-C)(Beidel et al., 1998, 2000) is a 26-item, self-report measure exploring anxiety in social situations. Responses are indicated using a 3-point Likert scale from 0 = never or hardly ever to 2 = most of the time or always with scores ranging from 0-52. Higher scores on the SPAI-C represent higher levels of social anxiety.

    Post-intervention (week 4), and 12-week follow-up

Secondary Outcomes (3)

  • Fear of Negative Evaluation at 4-week Post-Intervention and 12-week Follow-Up

    Post-intervention (week 4), and 12-week follow-up

  • Anxiety Related Disorders at 4-week Post-intervention and 12-week Follow-up

    Post-intervention (week 4), and 12-week follow-up

  • Depression Symptoms at 4-week Post-intervention and 12-week Follow-up

    Post-intervention (week 4), and 12-week follow-up

Study Arms (2)

Placebo

PLACEBO COMPARATOR

The placebo protocol consists of 160 trials (120 angry-neutral face pair and 40 neutral-neutral face pair presentations). In this condition, angry-face location, probe location and actor are fully counterbalanced in presentation. A short break is delivered every 40 trials (1 block). An accuracy of 70% or above for each block is necessary to continue training. The task takes 7 minutes.

Other: Placebo

Intervention

EXPERIMENTAL

The attention bias modification training (ABMT) protocol consists of 160 trials (120 angry-neutral face pair presentations and 40 neutral-neutral face pair presentations). In the ABM condition, the target-probe appears at the neutral-face locations in all angry-neutral trials. A short break is delivered every 40 trials (1 block). An accuracy of 70% or above for each block is necessary to continue training. The task takes 7 minutes.

Behavioral: ABMT

Interventions

ABMTBEHAVIORAL

Attention Bias Modification Training

Intervention
PlaceboOTHER

Placebo Training

Placebo

Eligibility Criteria

Age15 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Those who score above the cut-off on the SPAI-C

You may not qualify if:

  • Those with a diagnosed mental health disorder
  • Those who are currently attending a mental health professional
  • Those scoring below the cut-off on the SPAI-C
  • Those who decline to participate
  • Those whose parents/guardians do not provide written consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (23)

  • Wittchen HU, Fehm L. Epidemiology and natural course of social fears and social phobia. Acta Psychiatr Scand Suppl. 2003;(417):4-18. doi: 10.1034/j.1600-0447.108.s417.1.x.

    PMID: 12950432BACKGROUND
  • Wittchen HU, Carter RM, Pfister H, Montgomery SA, Kessler RC. Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. Int Clin Psychopharmacol. 2000 Nov;15(6):319-28. doi: 10.1097/00004850-200015060-00002.

    PMID: 11110007BACKGROUND
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA, American Psychiatric Association, 2013.

    BACKGROUND
  • Neil AL, Christensen H. Efficacy and effectiveness of school-based prevention and early intervention programs for anxiety. Clin Psychol Rev. 2009 Apr;29(3):208-15. doi: 10.1016/j.cpr.2009.01.002. Epub 2009 Jan 25.

    PMID: 19232805BACKGROUND
  • Otto MW, Smits JA, Reese HE. Cognitive-behavioral therapy for the treatment of anxiety disorders. J Clin Psychiatry. 2004;65 Suppl 5:34-41.

    PMID: 15078117BACKGROUND
  • Macleod C. Cognitive bias modification procedures in the management of mental disorders. Curr Opin Psychiatry. 2012 Mar;25(2):114-20. doi: 10.1097/YCO.0b013e32834fda4a.

    PMID: 22227631BACKGROUND
  • Mathews A, MacLeod C. Induced processing biases have causal effects on anxiety. Cognition and Emotion 16(3): 331-354, 2002.

    BACKGROUND
  • Mogg K, Bradley BP. A cognitive-motivational analysis of anxiety. Behav Res Ther. 1998 Sep;36(9):809-48. doi: 10.1016/s0005-7967(98)00063-1.

    PMID: 9701859BACKGROUND
  • Amir N, Weber G, Beard C, Bomyea J, Taylor CT. The effect of a single-session attention modification program on response to a public-speaking challenge in socially anxious individuals. J Abnorm Psychol. 2008 Nov;117(4):860-868. doi: 10.1037/a0013445.

    PMID: 19025232BACKGROUND
  • Klumpp H, Amir N. Examination of vigilance and disengagement of threat in social anxiety with a probe detection task. Anxiety Stress Coping. 2009 May;22(3):283-96. doi: 10.1080/10615800802449602.

    PMID: 19253172BACKGROUND
  • Sportel BE, de Hullu E, de Jong PJ, Nauta MH. Cognitive bias modification versus CBT in reducing adolescent social anxiety: a randomized controlled trial. PLoS One. 2013 May 14;8(5):e64355. doi: 10.1371/journal.pone.0064355. Print 2013.

    PMID: 23691203BACKGROUND
  • Beard C, Weisberg RB, Amir N. Combined cognitive bias modification treatment for social anxiety disorder: a pilot trial. Depress Anxiety. 2011 Nov;28(11):981-8. doi: 10.1002/da.20873. Epub 2011 Sep 2.

    PMID: 21898705BACKGROUND
  • Emmelkamp PM. Attention bias modification: the Emperor's new suit? BMC Med. 2012 Jun 25;10:63. doi: 10.1186/1741-7015-10-63.

    PMID: 22731990BACKGROUND
  • Merikangas KR, He JP, Burstein M, Swanson SA, Avenevoli S, Cui L, Benjet C, Georgiades K, Swendsen J. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9. doi: 10.1016/j.jaac.2010.05.017. Epub 2010 Jul 31.

    PMID: 20855043BACKGROUND
  • Carleton RN, McCreary DR, Norton PJ, Asmundson GJ. Brief fear of negative evaluation scale-revised. Depress Anxiety. 2006;23(5):297-303. doi: 10.1002/da.20142.

    PMID: 16688736BACKGROUND
  • Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry. 1999 Oct;38(10):1230-6. doi: 10.1097/00004583-199910000-00011.

    PMID: 10517055BACKGROUND
  • Crocetti E, Hale WW 3rd, Fermani A, Raaijmakers Q, Meeus W. Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED) in the general Italian adolescent population: a validation and a comparison between Italy and The Netherlands. J Anxiety Disord. 2009 Aug;23(6):824-9. doi: 10.1016/j.janxdis.2009.04.003. Epub 2009 Apr 23.

    PMID: 19427168BACKGROUND
  • Chorpita BF, Yim L, Moffitt C, Umemoto LA, Francis SE. Assessment of symptoms of DSM-IV anxiety and depression in children: a revised child anxiety and depression scale. Behav Res Ther. 2000 Aug;38(8):835-55. doi: 10.1016/s0005-7967(99)00130-8.

    PMID: 10937431BACKGROUND
  • Tottenham N, Tanaka JW, Leon AC, McCarry T, Nurse M, Hare TA, Marcus DJ, Westerlund A, Casey BJ, Nelson C. The NimStim set of facial expressions: judgments from untrained research participants. Psychiatry Res. 2009 Aug 15;168(3):242-9. doi: 10.1016/j.psychres.2008.05.006. Epub 2009 Jun 28.

    PMID: 19564050BACKGROUND
  • Mathyssek CM, Olino TM, Hartman CA, Ormel J, Verhulst FC, Van Oort FV. Does the Revised Child Anxiety and Depression Scale (RCADS) measure anxiety symptoms consistently across adolescence? The TRAILS study. Int J Methods Psychiatr Res. 2013 Mar;22(1):27-35. doi: 10.1002/mpr.1380. Epub 2013 Mar 11.

    PMID: 23483654BACKGROUND
  • Inderbitzen-Nolan H, Davies CA, McKeon ND. Investigating the construct validity of the SPAI-C: comparing the sensitivity and specificity of the SPAI-C and the SAS-A. J Anxiety Disord. 2004;18(4):547-60. doi: 10.1016/S0887-6185(03)00042-2.

    PMID: 15149713BACKGROUND
  • EU Commission. Toolkit Gender in EU-funded research. Luxembourg, Publications Office of the European Union, 2007.

    BACKGROUND
  • Beidel DC, Turner SM, Morris The Social Phobia and Anxiety Inventory for Children (SPAI-C). Toronto, ON, Multi-Health Systems, 1998.

    BACKGROUND

MeSH Terms

Conditions

Anxiety DisordersDepressionPhobia, Social

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehaviorPhobic Disorders

Results Point of Contact

Title
Dr Amanda Fitzgerald
Organization
University College Dublin

Study Officials

  • Amanda Fitzgerald, Ph.D.

    University College Dublin

    PRINCIPAL INVESTIGATOR
  • Barbara Dooley, Ph.D.

    University College Dublin

    PRINCIPAL INVESTIGATOR
  • Yair Bar-Haim, Ph.D.

    Tel Aviv University

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

October 9, 2014

First Posted

October 21, 2014

Study Start

October 1, 2014

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

November 20, 2018

Results First Posted

November 20, 2018

Record last verified: 2018-11